Skip to main content
Utkarsh Acharya, DO, Oncology, Columbus, OH, The OSUCCC - James

UtkarshAcharyaDOFACP

Oncology • Columbus, OH

Hematologic Oncology

Board certified hematologist-medical oncologist with expertise in cellular immunotherapy on faculty at The Ohio State University Wexner Medical Center / James Cancer Hospital. Prior faculty positions at Dana-Farber Cancer Institute / Harvard Medical School and Fred Hutch Cancer Center / University of Washington.

Join to view full profile

Dr. Acharya is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Acharya's full profile

Already have an account?

Summary

  • Utkarsh Acharya, DO, FACP - Dana-Farber Cancer Institute | Boston, MA

    Dr. Acharya is a medical oncologist treating patients with hematologic malignancies with clinical expertise in chimeric antigen receptor (CAR) T cell therapy.

    Utkarsh Acharya, DO, FACP

    Dr Acharya serves as an attending physician at the SCCA Bezos Family Immunotherapy Clinic and on the inpatient Immunotherapy service at UWMC.

    Utkarsh Acharya | D.O., F.A.C.P. | Hematology Oncology | UW Medicine | UW Medici

    Utkarsh Acharya, D.O., F.A.C.P., is a board certified hematology oncologist at SCCA and UW Medical Center and a UW assistant professor of Oncology.

Clinical Expertise

  • Hematology, Medical oncology, Adoptive immunotherapy, Hematologic oncology, Leukemia, Lymphoma, Multiple myeloma, Myelodysplasia, Myelofibrosis, T-cell adoptive tumor therapy, Acute myeloid leukemia

Education & Training

  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 2010 - 2012
  • University of South Florida Morsani
    University of South Florida MorsaniInternship, Internal Medicine, 2009 - 2010
  • Ohio University Heritage College of Osteopathic Medicine in Athens
    Ohio University Heritage College of Osteopathic Medicine in AthensClass of 2009
  • Wilmington College
    Wilmington CollegeB.S, Major: Biology/ Minor: Chemistry, 2004

Certifications & Licensure

  • MA State Medical License
    MA State License 2018 - 2025
  • OH State Medical License
    OH State License 2010 - 2025
  • WA State Medical License
    WA State License 2016 - 2025
  • AZ State Medical License
    AZ State License 2012 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Fellow American College of Physicians, 2015
  • Member Alpha Omega Medical Honor Society
  • Member Arnold P Gold Humanism Honor Society

Publications & Presentations

PubMed

Journal Articles

  • DVT prophylaxis in long term care facilities - perhaps less is more.  
    Acharya U, Khan S, Journal of American Medical Directors Association;12(4):313
  • Teretocarcinoma in a Young Man with Testicular Torsion.  
    Acharya U, Stroble S, Pepe L, Miocinovic R, Journal of histotechnology
  • It doesn’t matter which sex students are.  
    Acharya, U, studentBMJ ;14:89

Books/Book Chapters

  • Hematology Rapid Review 
    Utkarsh Acharya & Tejaswini DhawaleEditors: Utkarsh Acharya & Tejaswini Dhawale.Wolters KluwerEdition 1st,2021
  • Oncology Rapid Review 
    Utkarsh Acharya & Tejaswini DhawaleEditors: Utkarsh Acharya & Tejaswini Dhawale.Wolters KluwerEdition 1st,2021

Abstracts/Posters

  • Effects of Eukarytoic Cell Cycle Inhibitors on Toxoplasma gondii.
    Acharya U, Woodmansee, D, Annual Biomedical Research Conference for Medical Students, San Diego, CA
  • Effects of Ca2+/K+ flux on Trypanosoma cruzii Egress.
    Acharya U, Rowland E, Ohio University College of Osteopathic Medicine, Athens, OH
  • Effects of Eukaryotic Cell Cycle Inhibitors on Toxoplasma gondii.
    Acharya U, Woodmansee, D, American Society for Microbiology103rd General Meeting, Washington, D.C
  • Join now to see all

Other

Authored Content

  • The COVID-19 Conundrum & Cancer - Making Perfect Sense of Imperfect DataMay 2020

Press Mentions

  • Dr. Utkarsh Acharya: On the Challenges, Pride and Frustrations of Treating CAR-T Patients
    Dr. Utkarsh Acharya: On the Challenges, Pride and Frustrations of Treating CAR-T PatientsNovember 12th, 2018
  • Dr. Utkarsh Acharya: On “Why Become Involved in Immunotherapy and Cellular Therapies for Treating Cancer?”
    Dr. Utkarsh Acharya: On “Why Become Involved in Immunotherapy and Cellular Therapies for Treating Cancer?”October 27th, 2018
  • Part 2: Why Seattle for My CAR-T Therapy to Demolish My CLL?
    Part 2: Why Seattle for My CAR-T Therapy to Demolish My CLL?April 5th, 2018

Professional Memberships

Other Languages

  • Gujarati

Hospital Affiliations

Industry Relationships

  • Medical Director, Bristol Myers SquibbMedical director in the cell therapy group of Bristol Myers Squibb.2022 - 2023

Dr. Utkarsh Acharya, Dr. Utkarsh Acharya, DO, Dr. U Acharya